AlphaYouSB
Insider selling
Stephen Basil Thomas sold $1.4M of Climb Bio, Inc. (CLYM) stock
Stephen Basil Thomas, Dir of Climb Bio, Inc. (CLYM), sold 100,000 shares of CLYM stock worth $1.4M, per an SEC Form 4 filed Sep 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 15, 2026, 2 days before it was made public.
CLYM has moved +2.2% since the trade date, from $13.91 to $14.21 (Sep 22, 2026 close).
- Traded
- Sep 15, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 2 days
- Price since
- +2.2%
- Role
- Dir
- Source
- SEC Form 4
More CLYM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.